Eris Lifesciences Limited IPO Message Board (Page 25)

105. DHIRAJLAL | Link | Bookmark | June 16, 2017 9:38:46 AM

apply ?

104. Eagleye | Link | Bookmark | June 15, 2017 11:04:22 PM

IPO Guru (6600+ Posts, 22000+ Likes)

Eris LifeSciences IPO
GMP 62 â€“ 63

104.1. MINTO | Link | Bookmark | June 16, 2017 8:18:01 AM

Top Contributor (400+ Posts, 400+ Likes)

apply or not???

103. Jaggu | Link | Bookmark | June 16, 2017 5:28:58 AM

Apply Or Avoid ?

102. Anandk | Link | Bookmark | June 15, 2017 10:20:43 PM

Overvalued.

101. ultrasnow | Link | Bookmark | June 15, 2017 9:35:21 PM

My humble one line review:

Instead of applying for 24 shares of Eris, please buy 12 shares of Lupin

100. Subbareddy | Link | Bookmark | June 15, 2017 8:13:25 PM

Its price is very high, is it bigger than alkem, it was 1050@ face value of 2. Here it is 603 @ face value of 1

99. Subbareddy | Link | Bookmark | June 15, 2017 8:08:31 PM

Guys there are many ipo''s this month. Its confusing a bit. So pls post ur view eighteen subscribe or avoid.

98. prabhup | Link | Bookmark | June 15, 2017 12:38:43 PM

SEPTA sir ..please give ur views on Glenmark..can i accumulate Glenmark at current price.. what is possibe downside ..please reply

97. wow | Link | Bookmark | June 15, 2017 12:38:26 PM

Generic drug approvals and regulatory inspections are important for the increase of price. Expected GMP:72-75
It may take more time for bullish. Long term investors this stock will be useful.

96. ANAND PARMAR | Link | Bookmark | June 15, 2017 12:05:22 PM

Eris
Kostak

95. Eagleye | Link | Bookmark | June 15, 2017 12:36:59 AM

IPO Guru (6600+ Posts, 22000+ Likes)

Eris LifeSciences IPO
GMP 73 â€“ 76

95.1. MINTO | Link | Bookmark | June 15, 2017 12:39:53 AM

Top Contributor (400+ Posts, 400+ Likes)

Thanks
But you applying
Tejas &Eris.
Please tell.

94. Eagleye | Link | Bookmark | June 15, 2017 12:36:40 AM

IPO Guru (6600+ Posts, 22000+ Likes)

Eris LifeSciences IPO
GMP 73 â€“ 76

93. Viraj. | Link | Bookmark | June 14, 2017 6:59:06 PM

IPO Mentor (900+ Posts, 1100+ Likes)

Dear Eagleye ,

after tejas what about view of eris r y apply..?

92. Advisory IPO | Link | Bookmark | June 14, 2017 6:35:14 PM

During Fiscal 2016, interim dividend of INR 6,042.00 per equity share on 137,500 equity shares of our Company of face value of INR 10 each, amounting to a total of INR 830.78 million, was declared and paid.

91. moneymarket | Link | Bookmark | June 13, 2017 11:16:05 AM

Eagleye, Septa--
If growth of this company is good, Why most of the promoters are selling?
When past growth is good, why PE ChrysCapital is exiting 100%?
Do they dont have confidence on future growth?

Load more comments (4 replies)

91.5. chitra kamat | Link | Bookmark | June 14, 2017 12:32:02 PM (200+ Posts, 200+ Likes)

PE do not hold for an indefinite time. Chrys is existing at around 39% profit. The promoter group continues to hold majority shares.

91.6. Maniac | Link | Bookmark | June 14, 2017 5:36:13 PM

@. 86.5. chitra kamat
Hey| of course PE doesnt hold indefinitely. But then what does? Do you know of a thing that can last forever? Come on now,...Even the time would come to a screeching hault someday.
Okay... let''s ignore the screeching part but yes nothing, no state, concept can hold true forever. Investing is delicately dangerous,much like the love..One needs to be blindfolded before taking such risks.Would you want to disagree?

90. Shrewd Trader | Link | Bookmark | June 14, 2017 4:17:09 PM

What is good for the stock is no fear of US FDA, and its manufacturing base being in Assam too is not a concern.
I hope no data fudging or smart accounting practices has been embraced.

89. Shrewd Trader | Link | Bookmark | June 14, 2017 4:14:14 PM

What is strange is the view- As per FY 16 data this issue is overpriced but if we annualize the FY 17 data this issue seems a value buy- all thanks to reduced FY 17 expenses.
In EV terms too issue looks Expensive.
SPT has clearly considered FY 17 Annu. figures to roll out his verdict and thus ignored the older data. Geogit has cautioned retail investors to stay away from this issue.

88. jajo | Link | Bookmark | June 14, 2017 4:04:32 PM

Top Contributor (300+ Posts, 200+ Likes)

After getting into serious regulatory issues with USFDA, back home Indian Pharma companies are likely to face Indian drug regulator with tightening norms. A news item in Moneycontrol.com reports " Indian drug regulator tightens quality norms, expects more compliance implementation, uniform quality standards has become imperative as the government proposes to implement generics only prescription policy...........
Not a rosy picture for only India based companies also.

87. SKGKOL | Link | Bookmark | June 14, 2017 12:29:17 PM

Friends
I want to know can I apply & submit application forms at mumbai asba account
My DP at kolkata
My Bank account at kolkata
I am temporary going to mumbai & want
TO submit applications of my family members
From mumbai

87.1. PRKSH | Link | Bookmark | June 14, 2017 3:21:32 PM

YES YOU CAN.. BUT PROVIDE DETAIL CORRECTLY

86. Eagleye | Link | Bookmark | June 14, 2017 2:03:17 PM

IPO Guru (6600+ Posts, 22000+ Likes)

Eris LifeSciences IPO
GMP 70 â€“ 73